REGISTERED NUMBER: 09534455 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

AG-Bio Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Dr P E V Williams

Ms W Robertson

REGISTERED OFFICE:

149 The Green

Worsley

Manchester

M28 2PA

REGISTERED NUMBER:

09534455 (England and Wales)

FIXED ASSETS

Tangible assets

4

19,629

23,860

CURRENT ASSETS

Debtors

5

2,599

15,661

Cash at bank

78,453

74,845

81,052

90,506

CREDITORS

Amounts falling due within one year

6

12,895

18,384

NET CURRENT ASSETS

68,157

72,122

TOTAL ASSETS LESS CURRENT LIABILITIES

87,786

95,982

PROVISIONS FOR LIABILITIES

3,476

4,533

NET ASSETS

84,310

91,449

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

84,210

91,349

84,310

91,449

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 November 2025 and were signed on its behalf by:

Dr P E V Williams - Director

1.	STATUTORY INFORMATION

AG-Bio Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

10% on cost

Plant and machinery

-

15% on cost

Computer equipment

-

25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2024

and 31 March 2025

39,618

DEPRECIATION

At 1 April 2024

15,758

Charge for year

4,231

At 31 March 2025

19,989

NET BOOK VALUE

At 31 March 2025

19,629

At 31 March 2024

23,860

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Other debtors

2,599

15,661

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Taxation and social security

10,735

16,150

Other creditors

2,160

2,234

12,895

18,384

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

31.3.25

31.3.24

£

£

Balancing owing from director at year end

2,599

15,660

Maximum balance outstanding during the year

29,292

18,024

Interest charged at 2.25%

594

222